Zobrazeno 1 - 10
of 438
pro vyhledávání: '"Hbsag seroclearance"'
Autor:
Jimmy Che-To Lai, Vicki Wing-Ki Hui, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip
Publikováno v:
Exploration of Digestive Diseases, Vol 3, Iss 3, Pp 175-189 (2024)
Hepatitis B surface antigen (HBsAg) seroclearance is considered the functional cure and the optimal treatment endpoint for chronic hepatitis B (CHB). Patients with CHB who cleared HBsAg generally have a favorable clinical course with minimal risk of
Externí odkaz:
https://doaj.org/article/e8100c1f2fde4df2bbad6ccd59a0d28a
Autor:
Anna Morrone, Valerio Fiorilli, Lilia Cinti, Piergiorgio Roberto, Alejandro L. Ferri, Marcella Visentini, Alessandro Pulsoni, Francesca Romana Spinelli, Adriano De Santis, Guido Antonelli, Stefania Basili, Maria Elena Tosti, Fabrizio Conti, Milvia Casato
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Mixed cryoglobulinemia vasculitis (MCV) is caused in ~90% of cases by chronic hepatitis C virus (HCVposMCV) and more rarely by hepatitis B virus (HBV) infection, or apparently noninfectious. HCVposMCV develops in only ~5% of patients with chronic hep
Externí odkaz:
https://doaj.org/article/0dd3293bdcfd487d91b45fb69b619e79
Autor:
Zongqi Shi, Huizhi Zheng, Miaomiao Han, Jieli Hu, Yuan Hu, Xiaosong Li, Wenyan Zhu, Xinjun He, Haijun Deng, Quanxin Long, Ailong Huang
Publikováno v:
Genes and Diseases, Vol 10, Iss 3, Pp 1019-1028 (2023)
Little is known about the difference in durability of HBsAg seroclearance induced by nucleoside analogs (NAs) or by interferon (IFN). A real-world, retrospective cohort study was conducted. Patients were assigned into two groups: NAs monotherapy-indu
Externí odkaz:
https://doaj.org/article/5d3d6c25bf4e458688f9d95f84516ce6
Autor:
Chi-Ling Chen, Wei-Shiung Yang, Hwai-I. Yang, Chuen-Fei Chen, Li-Yu Wang, Sheng-Nan Lu, Jia-Horng Kao, Pei-Jer Chen, Chien-Jen Chen
Publikováno v:
Liver Cancer, Pp 1-1 (2024)
Introduction: Our previous nested-case-control study demonstrated elevated adiponectin increased liver cirrhosis and HCC risk in HBV carriers. We extended the analysis to the whole REVEAL-HBV cohort to prospectively evaluate whether adiponectin direc
Externí odkaz:
https://doaj.org/article/1c441ad4383146f493932492327d0764
Autor:
Yu Jun Wong, Vy H. Nguyen, Hwai-I Yang, Jie Li, Michael Huan Le, Wan-Jung Wu, Nicole Xinrong Han, Khi Yung Fong, Elizebeth Chen, Connie Wong, Fajuan Rui, Xiaoming Xu, Qi Xue, Xin Yu Hu, Wei Qiang Leow, George Boon-Bee Goh, Ramsey Cheung, Grace Wong, Vincent Wai-Sun Wong, Ming-Whei Yu, Mindie H. Nguyen
Publikováno v:
Clinical and Molecular Hepatology, Vol 29, Iss 3, Pp 705-720 (2023)
Background/Aims Chronic hepatitis B (CHB) and fatty liver (FL) often co-exist, but natural history data of this dual condition (CHB-FL) are sparse. Via a systematic review, conventional meta-analysis (MA) and individual patient-level data MA (IPDMA),
Externí odkaz:
https://doaj.org/article/844099d7500d4e8bad63598a5b9efd24
Autor:
Yisi Liu, Shan Ren, Lina Ma, Xiao Lin, Hong Li, Junfeng Lu, Zhenhuan Cao, Sujun Zheng, Zhongjie Hu, Xinyue Chen
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 27, Iss 6, Pp 103703- (2023)
Hepatitis B Surface Antigen (HBsAg) seroclearance is the highest treatment goal recommended by the current guidelines for hepatitis B. Levels of antibodies to HBsAg (anti-HBs) are strongly associated with HBsAg recurrence, but hepatitis B vaccination
Externí odkaz:
https://doaj.org/article/0634d318172d40a8a66d53a4992ac812
Publikováno v:
Journal of Hepatocellular Carcinoma, Vol Volume 9, Pp 301-313 (2022)
Rei-Chi Hsueh,1 Wan-Jung Wu,1 Chih-Lin Lin,2 Chun-Jen Liu,3 Yi-Wen Huang,4,5 Jui-Ting Hu,6 Chih-Feng Wu,1 Feng-Yu Sung,1 Wen-Jie Liu,1 Ming-Whei Yu1 1Graduate Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwa
Externí odkaz:
https://doaj.org/article/b0ab153519604e48aa93fc5216bb3fdd
Autor:
Michele Barone, Andrea Iannone, Martino Mezzapesa, Michele Milella, Francesco Di Gennaro, Grazia Niro, Rosa Cotugno, Raffaele Cozzolongo, Giuseppe Mennea, Maria Rendina, Alfredo Di Leo
Publikováno v:
Pathogens, Vol 12, Iss 10, p 1198 (2023)
Spontaneous HBsAg seroclearance has been mainly studied in populations from Asia, Australia, the Pacific Islands, and Polynesia. For the first time, we evaluated the spontaneous HBsAg seroclearance and its possible associated factors and the risk of
Externí odkaz:
https://doaj.org/article/602d16ca051f4623a0efdee6e071b15e
Autor:
Peipei Wang, Zhishuo Mo, Ying Zhang, Chunxia Guo, Trevor Kudzai Chikede, Dabiao Chen, Ziying Lei, Zhiliang Gao, Qian Zhang, Qiaoxia Tong
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
BackgroundKnowing about cytokine profile contributes to clarify the underling immune mechanism of HBsAg seroclearance rate increase. This study aims to investigate cytokine changes during nucleos(t)ide analogues (NAs) and peginterferon-α (Peg-IFNα)
Externí odkaz:
https://doaj.org/article/1e180699f8ec4e168702ebba0913ca70
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.